Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Faleck

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2019
ReplyDavid Faleck, Parambir Dulai, Ryan Ungaro
Lancet (London, England)|January 27, 2009
Response to medical students' letter of solidarity with GazaRebecca Braunstein, David Faleck, David Stern
Journal of Endourology|February 25, 2012
Minimally invasive heminephrectomy: feasibility and outcomesSteven Sobey, A Ari Hakimi, David Faleck, et al.
Journal for Immunotherapy of Cancer|January 19, 2024
Response to Yu and Fuhler <i>et al</i>Patrick Tiongco Magahis, Steven B Maron, David Faleck, et al.
Urology|August 27, 2010
The role of preoperative endo-rectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomyBarry M Mason, A Ari Hakimi, David Faleck, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitorsPatrick Tiongco Magahis, Tara Corso, Pamela Livingstone, et al.
Journal for Immunotherapy of Cancer|October 29, 2023
Impact of <i>Helicobacter pylori</i> infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitorsPatrick T Magahis, Steven B Maron, Darren Cowzer, et al.
Gut|August 23, 2018
Enterocolitis due to immune checkpoint inhibitors: a systematic reviewEmilie Soularue, Patricia Lepage, Jean Frederic Colombel, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2019
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre studyTomer Adar, David Faleck, Saranya Sasidharan, et al.
Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2019
ReplyDavid Faleck, Parambir Dulai, Ryan Ungaro
Lancet (London, England)|January 27, 2009
Response to medical students' letter of solidarity with GazaRebecca Braunstein, David Faleck, David Stern
Journal of Endourology|February 25, 2012
Minimally invasive heminephrectomy: feasibility and outcomesSteven Sobey, A Ari Hakimi, David Faleck, et al.
Journal for Immunotherapy of Cancer|January 19, 2024
Response to Yu and Fuhler <i>et al</i>Patrick Tiongco Magahis, Steven B Maron, David Faleck, et al.
Urology|August 27, 2010
The role of preoperative endo-rectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomyBarry M Mason, A Ari Hakimi, David Faleck, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitorsPatrick Tiongco Magahis, Tara Corso, Pamela Livingstone, et al.
Journal for Immunotherapy of Cancer|October 29, 2023
Impact of <i>Helicobacter pylori</i> infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitorsPatrick T Magahis, Steven B Maron, Darren Cowzer, et al.
Gut|August 23, 2018
Enterocolitis due to immune checkpoint inhibitors: a systematic reviewEmilie Soularue, Patricia Lepage, Jean Frederic Colombel, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2019
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre studyTomer Adar, David Faleck, Saranya Sasidharan, et al.
Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.
Pageof 3